GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/ unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy - Zhou, Qing; Chen, Ming; Wu, Gang; Chang, Jian-Hua; Jiang, Ou; Cui, Jiu-Wei; Han, Guang; Lin, Qin; Fang, Jian; Chen, Gong-Yan; Wu, Yi-Long (Translational Lung Cancer Research; Vol 9, No 5 (October 28, 2020): Translational Lung Cancer Research, 2020)